Investigational Site Number : 1560003

Zhengzhou 450008

0 studies enrolling now · 3 studies all time

What they study most

Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia Refractory, Blastic Plasmacytoid Dendritic Cell Neoplasia, Myelodysplastic Syndromes, Type 2 Diabetes Mellitus

Studies at this site

• First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) — Stopped early
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) — Stopped early
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea — Stopped early